APA (7th ed.) Citation
(2026). Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence. Rare Cancers and Therapy.
Chicago Style (17th ed.) Citation
"Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence." Rare Cancers and Therapy 2026.
MLA (9th ed.) Citation
"Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence." Rare Cancers and Therapy, 2026.
Warning: These citations may not always be 100% accurate.